Japan's Oncolys BioPharma wants to muscle in on Amgen's cancer-killing virus for melanoma. The biotech has filed to start trials of its version in U.…

Plans are being laid for India and the U.S. to work together on the development of vaccines for dengue fever and other diseases that pose a major threat to…

Bristol-Myers Squibb partner Ono Pharmaceutical bagged a third approval in Japan for immuno-oncology drug Opdivo, its most important new product.

Chairman Zhou Jie resigns just three months after taking on the role.

Chinese-American diagnostics specialist says it is building a new La Jolla lab to support U.S. product launches.

Chinese development venture will boost biotech R&D space in South San Francisco by a fifth, says city manager.

By selling its Wako chemicals unit, the top Japanese drugmaker Takeda could raise $1 billion for reinvestment in its pipeline.

Applications for clinical trials on genetic candidates in India can be sent at the same time to the Drug Controller General of India and the Review Committee…